Features | n | Median [25th;75th percentile] or n (%) |
---|---|---|
Epicardial adipose tissue (mL) | 1253 | 85 [60;115] |
Age (years) | 1253 | 61 [54;67] |
Sex (M, %) | 1253 | 720 (57) |
Diabetes duration (years) | 1239 | 11 [5;18] |
Hba1c (%) | 1239 | 7.5 [6.8;8.4] |
Body mass index (kg/m2) | 1215 | 28.7 [25.8;32.6] |
Obesity (≥ 30 kg/m2) | 1215 | 505 (42) |
Waist circumference (cm) | 895 | 104 [95;113] |
Hypertension | 1252 | 795 (63) |
Dyslipidemia | 1242 | 652 (52) |
Smoking exposure | 1197 | 505 (42) |
DT2 treatment | Â | Â |
- OADs | 1253 | 1078 (86) |
- GLP-1 | 1253 | 304 (24) |
- i-SGLT2 | 1253 | 20 (2) |
- Insulin | 1253 | 423 (34) |
Macroangiopathy | 1226 | 108 (9) |
Coronary artery disease | 1224 | 48 (4) |
Cerebrovascular disease | 1249 | 22 (2) |
Peripheral arterial occlusive disease | 1094 | 52 (5) |
Peripheral neuropathy | 1108 | 300 (27) |
Retinopathy (DR) (n,%) | 1253 | 399 (32) |
â–ª No DR: 854 | ||
▪ Mild NPDR: 201 | ||
▪ Moderate NPDR: 85 | ||
▪ Proliferative DR + laser: 76 | ||
â–ª Severe NPDR: 37 | ||
CKD (GFR < 60 et/ou ACR > 3) | 1240 | 429 (35) |
Total Cholesterol (mg/dL) | 1201 | 1.72 [1.49;2.02] |
HDL-Chol (mg/dL) | 1201 | 0.45 [0.38;0.53] |
LDL-Chol (mg/dL) | 1166 | 1.01 [0.79;1.22] |
Triglycerides (mg/dL) | 1204 | 1.22 [0.85;1.72] |
ASAT (UI/L) | 1192 | 25 [20;31] |
ALAT (UI/L) | 1197 | 25 [18;38] |
Gamma GT (UI/L) | 1196 | 31 [22;50] |
Uric acid (µM) | 1105 | 324.5 [273;383] |
Troponin (ng/mL) | 828 | 3 [3;4] |
BNP (ng/L) | 855 | 11.7 [10;27] |
High sensitive CRP (mg/L) | 862 | 2.1 [0.9;4.7] |
Fibrinogen (g/L) | 861 | 3.5 [3.0;4.0] |
Coronary artery calcium score (CAC) | 1247 | 20 [0;198] |
Creatininemia (µM) | 1169 | 70 [57.9;85] |
Albuminuria (mg/L) | 1211 | 12 [5;36] |
Proteinuria (g/L) | 1080 | 0.09 [0.07;0.15] |
Creatininuria (mmol/L) | 896 | 9.59 [5.78;14.00] |
Albumin/creatinin ratio (ACR) (mg/mmol) | 976 | 1.00 [0.53;2.82] |
Protein/creatinin ratio (g/mmol) | 698 | 0.010 [0.006;0.016] |
GFR CKD epi (mL/min/1,73 m2) | 1199 | 93 [77.9;102.6] |
KFRE (%) | 964 | 0.003 [0.001;0.020] |